WALTHAM, Mass., Jun 02, 2010 (BUSINESS WIRE) --Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Bank of America Merrill Lynch Smid Cap Conference on Wednesday, June 9, 2010, at 2:30 p.m. ET from the InterContinental Hotel in Boston. In addition, Alkermes' corporate presentation will be webcast live at the Jefferies Global Life Sciences Conference on Thursday, June 10, 2010, at 4:30 p.m. ET from the Grand Hyatt Hotel in New York City. The presentations may be accessed under the investor relations tab at www.alkermes.com. The presentations will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.
SOURCE: Alkermes
Alkermes, Inc.
Eva Stroynowski, 781-609-6823
Corporate Communications